A PYMNTS Company

Bausch & Lomb, Glaxo Unit Face Medical Antitrust Suit

By  |  December 9, 2021

Pharmavite, which markets Nature Made nutritional supplements, brought federal antitrust claims in Los Angeles against Bausch & Lomb and a GlaxoSmithKline Plc subsidiary, claiming they’re using sham patent litigation to clear the market for the “PreserVision” product line.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The lawsuit, filed late Wednesday, accuses the Glaxo and Bausch Health subsidiaries of wrongfully asserting their PreserVision patents against Pharmavite, which is owned by Otsuka Pharmaceutical Co.—despite the expiration of the main patent’s 20-year enforceability term.

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Although another patent is still in effect, it covers only a “narrow method” of administering the supplement, rather than the formulation itself, according to Bloomberg.

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.